Literature DB >> 11522706

Clinically useful estimates of insulin sensitivity during pregnancy: validation studies in women with normal glucose tolerance and gestational diabetes mellitus.

J P Kirwan1, L Huston-Presley, S C Kalhan, P M Catalano.   

Abstract

OBJECTIVE: We examined whether selected indexes of insulin sensitivity derived from an oral glucose tolerance test (IS(OGTT)) or fasting glucose/insulin levels (IS(QUICKI) and IS(HOMA)) can be used to predict insulin sensitivity in women before and during pregnancy. RESEARCH DESIGN AND METHODS: A 2-h euglycemic-hyperinsulinemic clamp (5 mmol/l glucose, 40 mU. m(-2). min(-1) insulin) and a 120-min oral glucose tolerance test (75 g load pregravid, 100 g pregnant) were repeated on 15 women (10 with normal glucose tolerance [NGT] and 5 with gestational diabetes mellitus [GDM]) pregravid and during both early (12-14 weeks) and late (34-36 weeks) pregnancy. An index of insulin sensitivity derived from the clamp (IS(CLAMP)) was obtained from glucose infusion rates adjusted for change in fat-free mass and endogenous glucose production measured using [6,6(-2)H(2)]glucose.
RESULTS: Univariate analysis using combined groups and periods of pregnancy resulted in significant correlations between IS(CLAMP) and IS(OGTT) (r(2) = 0.74, P < 0.0001), IS(QUICKI) (r(2) = 0.64, P < 0.0001), and IS(HOMA) (r(2) = 0.53, P < 0.0001). The IS(OGTT) provided a significantly better correlation (P < 0.0001) than either IS(QUICKI) or IS(HOMA.) Multivariate analysis showed a significant group effect (P < 0.0003) on the prediction model, and separate equations were developed for the NGT (r(2) = 0.64, P < 0.0001) and GDM (r(2) = 0.85, P < 0.0001) groups. When subdivided by period of pregnancy, the correlation between IS(CLAMP) and IS(OGTT) pregravid was r(2) = 0.63 (P = 0.0002), during early pregnancy was r(2) = 0.80 (P < 0.0001), and during late pregnancy was r(2) = 0.64 (P = 0.0002).
CONCLUSIONS: Estimates of insulin sensitivity from the IS(OGTT) during pregnancy were significantly better than from fasting glucose and insulin values. However, separate prediction equations are necessary for pregnant women with NGT and women with GDM.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11522706     DOI: 10.2337/diacare.24.9.1602

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  63 in total

1.  Roles of insulin resistance and beta cell dysfunction in macrosomia among Chinese women with gestational diabetes mellitus.

Authors:  Jing Li; Junhong Leng; Wei Li; Cuiping Zhang; Lingyan Feng; Peng Wang; Juliana C N Chan; Gang Hu; Zhijie Yu; Xilin Yang
Journal:  Prim Care Diabetes       Date:  2018-08-13       Impact factor: 2.459

2.  Evidence of mononuclear cell preactivation in the fasting state in polycystic ovary syndrome.

Authors:  Frank González; John P Kirwan; Neal S Rote; Judi Minium
Journal:  Am J Obstet Gynecol       Date:  2014-06-20       Impact factor: 8.661

3.  Late pregnancy complications in polycystic ovarian syndrome.

Authors:  I Katsikis; M Kita; A Karkanaki; N Prapas; D Panidis
Journal:  Hippokratia       Date:  2006-07       Impact factor: 0.471

4.  Secretion of incretin hormones and the insulinotropic effect of gastric inhibitory polypeptide in women with a history of gestational diabetes.

Authors:  J J Meier; B Gallwitz; M Askenas; K Vollmer; C F Deacon; J J Holst; W E Schmidt; M A Nauck
Journal:  Diabetologia       Date:  2005-07-12       Impact factor: 10.122

5.  Adiponectin and beta cell dysfunction in gestational diabetes: pathophysiological implications.

Authors:  R Retnakaran; A J G Hanley; N Raif; C R Hirning; P W Connelly; M Sermer; S E Kahn; B Zinman
Journal:  Diabetologia       Date:  2005-03-19       Impact factor: 10.122

6.  Circulating adipokines are associated with pre-eclampsia in women with type 1 diabetes.

Authors:  Clare B Kelly; Michelle B Hookham; Jeremy Y Yu; Samuel M Lockhart; Mei Du; Alicia J Jenkins; Alison Nankervis; Kristian F Hanssen; Tore Henriksen; Satish K Garg; Samar M Hammad; James A Scardo; Christopher E Aston; Christopher C Patterson; Timothy J Lyons
Journal:  Diabetologia       Date:  2017-09-05       Impact factor: 10.122

7.  An abnormal screening glucose challenge test in pregnancy predicts postpartum metabolic dysfunction, even when the antepartum oral glucose tolerance test is normal.

Authors:  Ravi Retnakaran; Ying Qi; Mathew Sermer; Philip W Connelly; Anthony J G Hanley; Bernard Zinman
Journal:  Clin Endocrinol (Oxf)       Date:  2008-10-21       Impact factor: 3.478

Review 8.  Maternal metabolism and obesity: modifiable determinants of pregnancy outcome.

Authors:  Scott M Nelson; Phillippa Matthews; Lucilla Poston
Journal:  Hum Reprod Update       Date:  2009-12-04       Impact factor: 15.610

9.  Prevention of gestational diabetes: feasibility issues for an exercise intervention in obese pregnant women.

Authors:  Leonie K Callaway; Paul B Colditz; Nuala M Byrne; Barbara E Lingwood; Ingrid J Rowlands; Katie Foxcroft; H David McIntyre
Journal:  Diabetes Care       Date:  2010-03-31       Impact factor: 19.112

10.  Estimates of insulin sensitivity using glucose and C-Peptide from the hyperglycemia and adverse pregnancy outcome glucose tolerance test.

Authors:  Tatjana Radaelli; Kristen Anne Farrell; Larraine Huston-Presley; Saeid Baradaran Amini; John Patrick Kirwan; Harold David McIntyre; Patrick Michael Catalano
Journal:  Diabetes Care       Date:  2009-12-23       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.